- Forums
- ASX - By Stock
- 1AD
- Ann: SYNThesis BioVentures MoU for cellular immunotherapies
Ann: SYNThesis BioVentures MoU for cellular immunotherapies, page-73
-
- There are more pages in this discussion • 54 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add 1AD (ASX) to my watchlist
(20min delay)
|
|||||
Last
2.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $14.89M |
Open | High | Low | Value | Volume |
2.5¢ | 2.5¢ | 2.5¢ | $850 | 34K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 2294371 | 2.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.6¢ | 687066 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 2279371 | 0.025 |
1 | 500000 | 0.024 |
1 | 45450 | 0.022 |
2 | 1047615 | 0.021 |
2 | 76547 | 0.020 |
Price($) | Vol. | No. |
---|---|---|
0.026 | 687066 | 3 |
0.027 | 458436 | 3 |
0.029 | 305304 | 2 |
0.030 | 300000 | 2 |
0.031 | 33000 | 1 |
Last trade - 10.00am 19/06/2024 (20 minute delay) ? |
Featured News
1AD (ASX) Chart |
The Watchlist
P.HOTC
HotCopper
Don Currie, CEO
Don Currie
CEO
Previous Video
Next Video
SPONSORED BY The Market Online